BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
X-WR-CALNAME:Chagas disease in non-endemic countries – strategies for scr
 eening and treating - Dr. David Hammer
X-WR-TIMEZONE:Eastern Time (US & Canada)
BEGIN:VEVENT
DTSTAMP:20260714T010724Z
UID:tag:localist.com\,2008:EventInstance_52196972041905
DTSTART:20260319T160000Z
DTEND:20260319T170000Z
DESCRIPTION:Davidson Hamer\, MD Davidson Hamer\, MD is a Professor of Globa
 l Health and Medicine at the Boston University Schools of Public Health an
 d Medicine\, the co-lead of the climate change and emerging infectious dis
 eases research core at the BU Center on Emerging Infectious Diseases\, and
  an attending physician in infectious diseases and Director of the Travel 
 Clinic at Boston Medical Center. Dr. Hamer is a board-certified infectious
  disease specialist and medical epidemiologist with particular interest in
  emerging arboviral diseases\, tropical medicine\, travel medicine\, infec
 tion control\, and antimicrobial resistance. \n\nDr. Hamer has been involv
 ed in travel medicine for thirty years and from 2014 to 2021\, Dr. Hamer s
 erved as the principal investigator and\, since September 2021\, as the Su
 rveillance Lead\, of GeoSentinel\, a global surveillance network of 70 sit
 es in 30 countries that uses returning travelers\, immigrants\, and refuge
 es as sentinels of disease emergence and transmission patterns throughout 
 the world. He also has been actively involved in enhanced screening for an
 d treatment of patients with Chagas disease at Boston Medical Center.\n\nD
 r. Hamer is currently the Scientific Program Chair for the American Societ
 y of Tropical Medicine and Hygiene and Section Editor the American Journal
  of Tropical Medicine and Hygiene (global health and Chagas disease). \n\n
 Title of Talk: Chagas disease in non-endemic countries – strategies for 
 screening and treating\n\nThere are an estimated 280\,000 or more people l
 iving with Chagas disease in the United States. Many of these people are i
 n the indeterminate phase of this chronic parasitic infection and approxim
 ately 30% of them will progress to develop chronic cardiac or gastrointest
 inal complications. This presentation will describe the epidemiology of Ch
 agas disease in endemic and non-endemic countries\, strategies to increase
  screening\, an approach to evaluation and treatment\, and potential compl
 ications of patients who have disease progression.
LOCATION:
SUMMARY:Chagas disease in non-endemic countries – strategies for screenin
 g and treating - Dr. David Hammer
URL;VALUE=URI:https://events.mountsinaihealth.org/event/chagas-disease-in-n
 on-endemic-countries-strategies-for-screening-and-treating-dr-david-hammer
CATEGORIES:Lecture/Seminar
END:VEVENT
END:VCALENDAR